Patents by Inventor Anders Dejgaard

Anders Dejgaard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10293109
    Abstract: A system for optimizing a patient's basal insulin dosage regimen over time, adapted to determine from blood glucose values whether and by how much to vary a patient's present recommended amount of the insulin-containing drug in order to maintain the patient's future blood glucose level measurements within a predefined range, and wherein a given blood glucose value is disregarded if no patient-actuated operation being indicative of the administration of a dose of an insulin containing drug has been detected in a pre-defined amount of time prior to the determination of the given blood glucose value.
    Type: Grant
    Filed: September 11, 2012
    Date of Patent: May 21, 2019
    Assignee: Novo Nordisk A/S
    Inventors: Henrik Bengtsson, Anders Dejgaard, Alan Moses
  • Publication number: 20140371682
    Abstract: A system for optimizing a patient's basal insulin dosage regimen over time, adapted to determine from blood glucose values whether and by how much to vary a patient's present recommended amount of the insulin-containing drug in order to maintain the patient's future blood glucose level measurements within a predefined range, and wherein a given blood glucose value is disregarded if no patient-actuated operation being indicative of the administration of a dose of an insulin containing drug has been detected in a pre-defined amount of time prior to the determination of the given blood glucose value.
    Type: Application
    Filed: September 11, 2012
    Publication date: December 18, 2014
    Applicant: NOVO NORDISK A/S
    Inventors: Henrik Bengtsson, Anders Dejgaard, Alan Moses